U.S. Organ Transplant Pharmaceuticals Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This report discusses in depth an emerging medical field dealing with the treatment of organ and tissue diseases through the replacement of defective organs with healthier, donated ones. The field of organ transplantation continues to evolve, as improved immunosuppression therapies emerge onto the market. These medicines increase the success of transplant survivals, and enable improved quality of life and contained healthcare costs. As research progresses, it is imperative for market participants to keep abreast of the leading issues and emerging therapies for organ transplant rejections. This report aims to provide participating companies with a tool to make market-intelligent decisions.

Table of Contents

U.S. Organ Transplant Pharmaceuticals Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Organ Transplant Pharmaceuticals Markets, Total MarketOverviewThe Immune System and Organ Transplant RejectionThe History of Organ Transplant ImmunosuppressionThe Nature of the MarketReport Scope and SegmentationMarket DynamicsChallengesDriversRestraintsMarket Engineering AnalysisForecasts and TrendsMarket and Technology TrendsRevenue ForecastsMarket Share AnalysisStrategic RecommendationsStrategic Recommendation 1Strategic Recommendation 2Strategic Recommendation 3Market Engineering AwardsProduct Line Strategy - Novartis Pharmaceutical CorporationTechnology Innovation - Isotechnika Inc.Market Penetration - Roche LaboratoriesProduct Innovation - SangStat Medical CorporationCompetitive Strategy Award- Abbott LaboratoriesU.S. Organ Transplant Pharmaceuticals Markets, Solid Organ Transplant Demand and Supply AnalysisTotal Demand and Supply AnalysisOverviewDemand and Supply Analysis by Organ TypeKidney TransplantsLiver TransplantsHeart TransplantsLung TransplantsPancreatic TransplantsIntestinal TransplantsCombined Organ TransplantsU.S. Organ Transplant Pharmaceuticals Markets, U.S. Chronic Immunosuppressant Therapies MarketOverviewIntroductionMarket and Technology TrendsMarket Engineering AnalysisForecasts and TrendsRevenue ForecastsRevenue Forecast AssumptionsMarket Share AnalysisDemand AnalysisPricing TrendsCompetitive AnalysisProduct Analysis - Calcineurin InhibitorsProduct Analysis - TOR InhibitorsProduct Analysis - AntimetabolitesProduct Analysis - CorticosteroidsCompetitive StructureEmerging TechnologiesBiotechnology TrendsProduct PipelineU.S. Organ Transplant Pharmaceuticals Markets, U.S. Acute Immunosuppressant Therapies MarketOverviewIntroductionMarket and Technology TrendsMarket Engineering AnalysisForecasts and TrendsRevenue Forecasts and AssumptionsMarket Share AnalysisDemand AnalysisPricing TrendsCompetitive AnalysisProduct Analysis - Prophylactic AgentsProduct Analysis - Acute Rejection Episode Treatment AgentsComparative StudiesCompetitive StructureProduct PipelineU.S. Organ Transplant Pharmaceuticals Markets, Decision Support DatabaseOrgan TransplantsNumber of Kidney TransplantsNumber of Heart TransplantsNumber of Liver TransplantsNumber of Pancreas TransplantsIncidence of Myocardial InfarctionHealthcare InfrastructureNumber of Specialized Medical PractitionersNumber of PharmacistsNumber of HospitalsDemographicsMale Population over 65 Years of AgeFemale Population over 65 years of AgeTotal Population over 65 Years of Age




Related Research

Release Date : 20-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.